Related references
Note: Only part of the references are listed.The current evidence on statin use and prostate cancer prevention: are we there yet?
Mahmoud A. Alfaqih et al.
NATURE REVIEWS UROLOGY (2017)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness
Thomas J. Schnoeller et al.
ONCOTARGET (2017)
Statin use and risk of disease recurrence and death after radical prostatectomy
Teemu Keskivali et al.
PROSTATE (2016)
Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis
A. D. Raval et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Statin Use in Prostate Cancer: An Update
Melissa A. Babcook et al.
NUTRITION AND METABOLIC INSIGHTS (2016)
The association between statin use and outcomes in patients initiating androgen deprivation therapy.
Robert James Hamilton et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
THE EFFECT OF NSAID USE ON DISEASE PROGRESSION IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
Gautum Agarwal et al.
JOURNAL OF UROLOGY (2015)
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C. Boutros et al.
NATURE GENETICS (2015)
A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer
Qian Sun et al.
PROSTATE (2015)
Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
M. Olivan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer
Lauren C. Harshman et al.
JAMA ONCOLOGY (2015)
Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins
Paula Vainio et al.
Oncotarget (2015)
Obesity Is Associated with Risk of Progression for Low-risk Prostate Cancers Managed Expectantly
Bimal Bhindi et al.
EUROPEAN UROLOGY (2014)
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
Neil E. Fleshner et al.
LANCET (2012)
Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Dipika Bansal et al.
PLOS ONE (2012)
Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives
Iris Postmus et al.
PHARMACOGENOMICS (2012)
Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer
Antonio Finelli et al.
EUROPEAN UROLOGY (2011)
ANALYSIS OF STATIN MEDICATION, GENETIC VARIATION AND PROSTATE CANCER OUTCOMES
Robert Hamilton et al.
JOURNAL OF UROLOGY (2011)
Impact of Common Medications on Serum Total Prostate-Specific Antigen Levels: Analysis of the National Health and Nutrition Examination Survey
Steven L. Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Statin and NSAID use and prostate cancer risk
Patricia F. Coogan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Elizabeth A. Platz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Statin use and risk of prostate cancer: Results from a population-based epidemiologic study
Ilir Agalliu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
The Influence of Statin Medications on Prostate-specific Antigen Levels
Robert J. Hamilton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Cholesterol-lowering drugs and advanced prostate cancer incidence in a large US cohort
Eric J. Jacobs et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Statin use and risk of prostate cancer in the California men's health study cohort
E. Dawn Flick et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
